Lisa A. Jackson, MD, MPH

Jackson_Lisa_A_205x293.jpg

“Kaiser Permanente Washington gives us nearly unlimited potential to address vaccine effectiveness and safety questions of national and international importance.”

Lisa A. Jackson, MD, MPH

Senior Investigator, Kaiser Permanente Washington Health Research Institute
Physician, Washington Permanente Medical Group, Internal Medicine

Biography

Lisa A. Jackson, MD, MPH, is an internist and infectious disease epidemiologist who has conducted clinical and epidemiologic studies of vaccine safety and efficacy since 1991. Dr. Jackson is the Kaiser Permanente Washington Health Research Institute (KPWHRI) principal investigator (PI) for the Vaccine Safety Datalink Project sponsored by the Centers for Disease Control and Prevention (CDC). She is also PI of the KPWHRI Vaccine and Treatment Evaluation Unit network site—one of nine network sites that the National Institutes of Health sponsors.

Dr. Jackson has written more than 200 peer-reviewed publications and 14 book chapters. She is a past member of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee and the National Vaccine Program Office’s National Vaccine Advisory Committee.

After receiving her medical degree from the University of Virginia School of Medicine, in Charlottesville, Dr. Jackson earned her Master of Public Health (MPH) degree at the University of Washington (UW) School of Public Health. She completed her internal medicine residency training at the UW School of Medicine and served as an epidemic intelligence officer and preventive medicine resident at the CDC.

A research professor in the UW Department of Epidemiology, Dr. Jackson is also an adjunct research professor in the UW Department of Medicine.

Research interests and experience

  • Vaccines & Infectious Diseases

    Vaccine  safety; influenza vaccine effectiveness in the elderly; methodologic issues in  vaccine effectiveness evaluations; pneumococcal polysaccharide vaccine  effectiveness; pneumococcal conjugate vaccine immunogenicity in the elderly;  epidemiology of E. coli bacteremia; epidemiology of community-acquired  pneumonia

 

Recent publications

Jackson LA, Kaufmann AF, Adams WG, Phelps MB, Andreasen C, Langkop CW, Francis BJ, Wenger JD. Outbreak of leptospirosis associated with swimming. Pediatr Infect Dis J. 1993;12(1):48-54. PubMed

Jackson LA, Wenger JD. Listeriosis: a foodborne disease. Infect Med. 1993;10(2):61-66.

Smith DK, Neal JJ, Holmberg SD and the Centers for Disease Control Idiopathic CD4+ T-Lymphocytopenia Task Force. Unexplained opportunistic infections and CD4 T-lymphocytopenia without HIV infection: an investigation of cases in the United States. N Engl J Med. 1993;328:373-379. PubMed

Jackson LA, Schuchat A. Reporting of toxic shock syndrome. J Infect Dis. 1992;166:445.

Schwartz B, Jackson LA. Invasive group B streptococcal disease in adults. JAMA. 1991;266:3284.

Jick H, Dinan BJ, Hunter JR, Stergachis A, Ronning A, Perera DR, Madsen S, Nudelman PM. Tricyclic antidepressants and convulsions. J Clin Psychopharmacol. 1983;3(3):182-5. PubMed

 

research

Jennifer Haller, a clinical trial volunteer, receives the first-ever injection of an investigational vaccine for the coronavirus. Credit: Ted S. Warren / AP Photos

Kaiser Permanente launches first coronavirus vaccine trial

On March 16, 4 volunteers received an injection of an mRNA vaccine for COVID-19 in an NIH-funded trial in Seattle.

KPWHRI in the Media

Vaccine against new coronavirus

Clinical trials for novel coronavirus vaccine will take place at Seattle research institute

Seattle Times, Feb. 26, 2020

research

man-supine-thermometer-1col.jpg

Clinical trial of H7N9 bird flu vaccine starts at KPWHRI

Dr. Lisa A. Jackson leads national trial to explore improving immune responses to the vaccine.

Read it in News and Events.

research into action

Flu-vaccination-elderly-patients_1col.jpg

Can targeted flu vaccines lower the risk of hospitalization?

Dr. Paula Lozano explains how a Learning Health System project finds Kaiser Permanente Washington members who could benefit most from preventive services.

kpwhri in the media

Are we prepared for the next flu pandemic?

U.S. News & World Report, Jan 18, 2018